Stock Analiz

Petmed Express Inc. PETS

Retail-Drug Stores and Proprietary Stores · data as of November 13, 2026

$0.94Market cap $21M
Open the interactive analysis →

Petmed Express Inc. (PETS) is a consumer staples company listed in the US with a market value of about $21M. In the twelve months to September 30, 2026 it had revenue of $160M and net income of -$27M, a net margin of -17.0%.

Its overall Stock Analiz score is 0.8 out of 5 (weak). The strongest part is shareholder returns (3/5); the weakest is value (0/5).

Key numbers: 5-year revenue growth of -10% a year, a 5-year average ROIC of -38%.

About Petmed Express

Petmed Express is listed in the US and classified in retail-drug stores and proprietary stores. Revenue went from $229M in 2015 to $179M in 2026, a decline of about 2.2% a year. It was profitable in 7 of the last 10 years in our data. Its share count rose by 3% over three years (dilution for shareholders).

Score: 0.8 / 5

Value0/5
Future growth0/5
Track record0/5
Financial health1/5
Shareholder returns3/5

Checks passed

  • More cash than debt, or low debt to equity
  • Pays a dividend
  • Dividend 3 years in a row
  • Stock-based pay below 5% of revenue

Checks not passed

  • P/E below 25
  • P/E below the industry median
  • P/FCF below 20
  • Price below intrinsic value (DCF, moderate assumptions)
  • PEG below 1.5
  • Revenue growth above 10% last year
  • 3-year revenue growth above 10% a year
  • Profit margin improving

Valuation

P/E (TTM)—
Forward P/E—
P/FCF—
P/S0.1
P/B1.2
EV/EBITDA—
PEG—
Dividend yield0.01%
FCF yield-117.8%
Shareholder yield0.0%
Intrinsic value vs. price—

Growth and quality

Revenue growth (1 yr)-21.1%
Revenue growth (5 yrs, per year)-10.0%
EPS growth (5 yrs, per year)—
FCF growth (3 yrs, per year)—
Net margin (5-yr avg.)-5.7%
ROIC (5-yr avg.)-37.5%
Profitable years (of last 10)7
Years paying a dividend10

Financials, last 10 years

Fiscal yearTTM2026202520242023202220212020201920182017
Revenue$160M$179M$227M$274M$248M$272M$304M$284M$283M$274M$249M
Net income-$27M-$57M-$6M-$7M$5M$19M$24M$26M$38M$37M$24M
Free cash flow-$25M-$33M-$395000-$194000$23M$17M$38M$37M$45M$37M$37M
EPS (diluted)$-1.28$-2.74$-0.30$-0.37$0.25$0.92$1.19$1.29$1.84$1.82$1.17
Net margin-17.0%-32.0%-2.8%-2.7%2.1%6.9%7.9%9.1%13.3%13.6%9.6%
ROIC—-198.8%-1.4%-6.6%3.8%15.2%18.9%19.6%26.3%31.2%25.2%

From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.

Frequently asked questions

Does Petmed Express pay a dividend?

Yes. The dividend yield is about 0.01%, and it has paid dividends for 10 years in our data.

Is Petmed Express a good stock to buy?

We do not give buy or sell advice. Petmed Express scores 0.8 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.

Similar companies

Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.